These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 24912950)

  • 21. Sensitivity and specificity of simple erythrocyte osmotic fragility test for screening of alpha-thalassemia-1 and Beta-thalassemia trait in pregnant women.
    Tongprasert F; Sirichotiyakul S; Piyamongkol W; Tongsong T
    Gynecol Obstet Invest; 2010; 69(4):217-220. PubMed ID: 20068326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of osmotic fragility test and dichlorophenol indophenol precipitation test for screening of thalassemia and Hb E.
    Sangkitporn S; Sangkitporn S; Sangnoi A; Supangwiput O; Tanphaichitr VS
    Southeast Asian J Trop Med Public Health; 2005 Nov; 36(6):1538-42. PubMed ID: 16610659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improvement of alpha(0)-thalassemia screening using combined osmotic fragility, dichlorophenolindophenol and Hb H inclusion tests.
    Chaibunruang A; Pornphannukool S; Sae-Ung N; Fucharoen G; Sanchaisuriya K; Fucharoen S
    Clin Lab; 2010; 56(3-4):111-7. PubMed ID: 20476642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A simplified screening for alpha-thalassemia 1 (SEA type) using a combination of a modified osmotic fragility test and a direct PCR on whole blood cell lysates.
    Panyasai S; Sringam P; Fucharoen G; Sanchaisuriya K; Fucharoen S
    Acta Haematol; 2002; 108(2):74-8. PubMed ID: 12187024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic value of the glycerol lysis test.
    Zanella A; Milani S; Fagnani G; Mariani M; Sirchia G
    J Lab Clin Med; 1983 Nov; 102(5):743-50. PubMed ID: 6631168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensitivity and specificity of mean corpuscular hemoglobin (MCH): for screening alpha-thalassemia-1 trait and beta-thalassemia trait.
    Pranpanus S; Sirichotiyakul S; Srisupundit K; Tongsong T
    J Med Assoc Thai; 2009 Jun; 92(6):739-43. PubMed ID: 19530577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validity of Nestroft in screening and diagnosis of beta-thalassemia trait.
    Gomber S; Sanjeev ; Madan N
    J Trop Pediatr; 1997 Dec; 43(6):363-6. PubMed ID: 9476460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of a new osmotic test in the screening of heterozygous beta thalassemias.
    Anichini P; Reynaudo G; Pacini G
    Scand J Clin Lab Invest; 1983 Apr; 43(2):171-3. PubMed ID: 6612224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An "on the spot" test for targeted screening in index families of thalassaemia.
    Yazdani MS; Ahmed S
    J Pak Med Assoc; 2010 Jul; 60(7):521-3. PubMed ID: 20578597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of one tube osmotic fragility screening in detecting beta-thalassaemia trait.
    Kattamis C; Efremov G; Pootrakul S
    J Med Genet; 1981 Aug; 18(4):266-70. PubMed ID: 7277419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A newly modified hemoglobin H inclusion test as a secondary screening for α(0)-thalassemia in Southeast Asian populations.
    Fucharoen G; Yooyen K; Chaibunruang A; Fucharoen S
    Acta Haematol; 2014; 132(1):10-4. PubMed ID: 24356175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and hematological characteristics of beta-thalassemia trait in Gaziantep urban area, Turkey.
    Gurbak M; Sivasli E; Coskun Y; Bozkurt AI; Ergin A
    Pediatr Hematol Oncol; 2006; 23(5):419-25. PubMed ID: 16728362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison and evaluation of three screening tests of hereditary spherocytosis in Chinese patients.
    Tao YF; Deng ZF; Liao L; Qiu YL; Chen WQ; Lin FQ
    Ann Hematol; 2015 May; 94(5):747-51. PubMed ID: 25501660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NESTROFT as a screening test for the detection of thalassaemia & common haemoglobinopathies--an evaluation against a high performance liquid chromatographic method.
    Thomas S; Srivastava A; Jeyaseelan L; Dennison D; Chandy M
    Indian J Med Res; 1996 Aug; 104():194-7. PubMed ID: 8840659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methods for detection of beta-thalassemia trait for sickle cell screening programs.
    Honig GR; Hoversten GH
    Am J Med Technol; 1974 Dec; 40(12):523-8. PubMed ID: 4440708
    [No Abstract]   [Full Text] [Related]  

  • 36. NESTROFT: a screening test for beta thalassemia trait.
    Mehta BC
    Indian J Med Sci; 2002 Nov; 56(11):537-45. PubMed ID: 14510336
    [No Abstract]   [Full Text] [Related]  

  • 37. Prevention and control of thalassemia at Saraburi Regional Hospital.
    Chareonkul P; Kraisin J
    J Med Assoc Thai; 2004 Jan; 87(1):8-15. PubMed ID: 14971529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A simple screening test for the detection of heterozygous beta thalassemia.
    Thool AA; Walde MS; Shrikhande AV; Talib VH
    Indian J Pathol Microbiol; 1998 Oct; 41(4):423-6. PubMed ID: 9866902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum ferritin in beta-thalassemia trait.
    Loria A; Konijn AM; Hershko C
    Isr J Med Sci; 1978 Nov; 14(11):1127-31. PubMed ID: 750537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Negative predictive value of the chorionic villous sampling (CVS) in diagnosis of thalassemia in genetic laboratory of Dastgheib Hospital, Shiraz, Iran, 2012.
    Ghahramani F; Alimohamadi Y; Mahboubi M; Afrasiabi A
    Arch Iran Med; 2014 Jul; 17(7):483-5. PubMed ID: 24979560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.